Research suggests that Lactobacillus helveticus may support bone health by promoting bone formation and reducing bone breakdown, with findings consistently pointing in a supportive direction across the available studies. The evidence base consists entirely of animal studies — specifically rat models of calcium deficiency and surgically induced menopause — none of which are human clinical trials, which is an important limitation to keep in mind when interpreting these results. Studies indicate that the bacterium, whether administered directly as a probiotic or used to ferment a calcium supplement, appeared to improve bone density, structural integrity, and relevant blood and genetic markers related to bone metabolism. One study also found that Lactobacillus helveticus as a single strain outperformed a combination with Bifidobacterium longum, suggesting that probiotic blending does not automatically enhance outcomes, though all of these findings require validation in human trials before any firm conclusions about efficacy in people can be drawn.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Lactobacillus helveticus-Derived Whey-Calcium Chelate Promotes Calcium Absorp... | Other | 2024 | Supports | 100 |
| Lactobacillus helveticus (ATCC 27558) upregulates Runx2 and Bmp2 and modulate... | Other | 2018 | Supports | 95 |
| Assessing the effects of probiotic supplementation, single strain versus mixe... | Other | 2024 | Supports | 90 |